The value of fludarabine in addition to ARA-C and G-CSF in the treatment of patients with high-risk myelodysplastic syndromes and AML in elderly patients.
暂无分享，去创建一个
G. Peters | P. Sonneveld | W. Graveland | G. Ossenkoppele | G. Verhoef | B. Löwenberg | M. Delforge | L. Verdonck | P. Noordhuis | S. Daenen | P. Muus | D. Selleslag | D. Biesma | M. Schaafsma | P. Westveer | B. van der Holt